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Abstract
Objective: To determine the incidence of P. aeruginosa (PA) ICU pneumonia and its independent association with
PA colonization at ICU admission.
Methods: This was a post-hoc analysis of a prospectively collected cohort study. Adult ICU patients with a length
of stay of ≥48 h were included and assessed for microbiologically confirmed PA ICU pneumonia. Multivariate survival
analysis was performed, including the covariates age, gender, PA colonization at ICU admission, ICU admission specialty
and mechanical ventilation at ICU admission, while taking into account the effect of competing risks.
Results: We included 5093 patients, 2447 (48%) were tested for colonization; of those 226 (9.2%) were PA colonized at
ICU admission. The incidence of PA ICU pneumonia was 1.34% (n = 68). PA colonization was an independent risk factor
(subdistribution hazard ratio [SHR] 8.8; 95% confidence interval [CI] 4.9–15.7), as was mechanical ventilation
(SHR 5.3, 95% CI 2.7–10.6).
Conclusion: In this study the incidence of P. aeruginosa ICU pneumonia was 1.34%. Hazard ratios for PA colonized
patients compared to non-colonized to develop PA ICU pneumonia were 8.8. The high risk associated with P. aeruginosa
colonization for subsequent infection may offer a target for future interventions.
Introduction
P. aeruginosa (PA) is a frequently occurring nosocomial
pathogen, causing potentially life threating infections,
one of them being Intensive Care Unit (ICU) pneumo-
nia, or pneumonia acquired while hospitalized on the
ICU [1, 2]. PA colonization might be a risk factor for PA
ICU pneumonia, but the bacterium may also be an inno-
cent bystander in patients with pneumonia caused by
another pathogen [1, 3, 4]. The association between PA
carriage on ICU admission and the occurrence of PA
ICU pneumonia remains relatively unexplored.
Objective
To estimate the incidence of PA ICU pneumonia and its
independent association with PA colonization at ICU
admission.
Methods
This analysis was performed on the data of a prospect-
ively collected observational cohort study, performed in
a mixed ICU of a tertiary hospital in Belgium. Data on
epidemiology of ICU-acquired infections were collected
from January 2010 until June 2014, by means of the
locally developed COSARA software application, allow-
ing a continuous prospective registration of all infection-
and antibiotic-related data [5].
Adult patients with a length of stay of ≥48 h were in-
cluded; screening for PA was part of routine care in
patients with an expected length of stay of ≥48 h and
was based on endotracheal aspirate (ETA), oropharyn-
geal and/or rectal cultures. Pneumonia diagnosis was
based on radiologic criteria in combination with at least
1 clinical or laboratory criterion. Confirmed PA ICU
pneumonia cases are those with pneumonia occurring
≥48 h after ICU admission and laboratory isolation of
PA from any location in the lower respiratory tract. All
PA pneumonia diagnoses were cross-validated by trained
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research physicians. More information on the methods
of this analysis are described elsewhere [6].
Patients were regarded as PA colonized at ICU admission
if there was a PA positive screening sample or in case of
another PA positive respiratory/skin sample on ICU admis-
sion ±2 days and if there was no PA infection diagnosed on
these days. The incidence density of PA ICU pneumonia
was determined using a Cox survival analysis that allows
controlling for competing events for the occurrence of ICU
pneumonia, in this case ICU discharge/death without ICU
pneumonia. The final model yielded subdistribution hazard
ratios (SHRs) reflecting the relative effect estimates that
account for competing events and the other covariates
included in the model. The included covariates were age
(as a continuous variable), gender, PA colonization at ICU
admission, ICU admission specialty (medical vs. surgical)
and mechanical ventilation at ICU admission.
Results
Data were collected from 5093 patients, of whom baseline
characteristics can be found in Table 1. A total of 2447
patients (48%) were tested for PA colonization at ICU
admission; of those 226 (9.2%) were PA colonized. A total
of 675 (13.3) patients developed ICU pneumonia. Micro-
biologically confirmed PA ICU pneumonia occurred in 68
patients (1.34%). In PA colonized patients PA ICU pneu-
monia occurred in 9.3% (n = 21); in confirmed non-
colonized it occurred in 1.1% (n = 25). The median time to
PA ICU pneumonia was 7 days. PA colonization was a risk
factor for the development of PA ICU pneumonia with a
cause-specific hazard ratio (CSHR) of 9.6 (95% CI 5.3–
17.2, p < 0.001). Mechanical ventilation at ICU admission
was associated with higher CSHR for developing PA ICU
pneumonia (CSHR 2.9; 95% CI 1.4–6.0; p = 0.004). After
accounting for competing events, PA colonization at ad-
mission remained a risk factor for the development of PA
ICU-pneumonia (SHR 8.8, 95% CI 5.0–15.7, p < 0.001,
Table 1, Fig. 1), as was mechanical ventilation at ICU
admission (SHR 5.3, 95% CI 2.7–10.5, p < 0.001).
Discussion
In this study PA colonized ICU patients with a length of
stay of ≥48 h had an almost nine times higher risk of de-
veloping PA ICU pneumonia than non-colonized pa-
tients. Studies that investigate PA colonization as a risk
factor for subsequent PA infection are very scarce, and
they do not perform multivariate time-to-event analysis
in combination with competing risk analyses [3, 4, 7–9].
This study has several limitations, one of them being a
single-center study, another being the fact that only half
of the patients were tested for PA colonization at ICU
admission. Reasons for not testing included the antici-
pated short stay on ICU for post-surgical patients. Un-
fortunately, reasons for admission were not recorded
and thus we cannot validate this explanation. A second
draw-back is the relatively high number of pneumonias
caused by unknown pathogens. We cannot rule out that
these were caused by (non-cultured) P. aeruginosa.
However, we performed a sensitivity analyses taking into
account pneumonias caused by other and unknown
Table 1 Baseline characteristics and subdistribution hazard ratio
(SHR) for P. aeruginosa ICU pneumonia
N (%) or
mean (SD)
SHR (95% CI) p
Gender: femalea 1915 (37.6) 0.73 (0.43–1.24) 0.24
Ageb 59.4 (16.1) 0.99 (0.98–1.01) 0.43
Length of stay in days 9.1 (11.7) - -
Median 5.0
Medical admissionc 2176 (42.7) 1.34 (0.82–2.20) 0.24
Colonization status at
ICU admission
- PA – 2221 (43.6) ref ref
- PA + 226 (4.4) 8.84 (4.96–15.74) <0.001*
- Unknown/missing 2645 (51.9) 1.04 (0.58–1.86) 0.89
ICU mortality 691 (13.6) - -
Mechanical ventilation at ICU
admission
2591 (50.9) 5.2 (2.70–10.47) <0.001*
ICU pneumonia 675 (13.3) - -
- PA 68 (1.3)
- other confirmed pathogen 347 (6.8)
- unknown pathogen 260 (5.1)
amale gender is reference category, bSHR per extra year of age, csurgical admission
is reference category
*significant at the 0.05 level
- = not measured/not applicable
Fig. 1 Cumulative incidence function. Cumulative risk of acquiring P.
aeruginosa ICU pneumonia
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pathogens as competing events, to assess if this changed
our final estimates. This was not the case.
Despite the limitations, this study suggests that previ-
ous PA colonization contributes to the development of
PA ICU pneumonia. Identifying patients at higher risk
for developing subsequent infection is important in case
that preventive medication becomes available, but also
when empirical therapy needs to be started.
Conclusion
In this study the incidence of P. aeruginosa ICU pneu-
monia was 1.34%. Hazard ratios for PA colonized pa-
tients compared to non-colonized to develop PA ICU
pneumonia were 8.8.
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